Monoclonal Antibody Therapy Clinic
Sault Area Hospital, in association with local and regional partners, is providing patients with the ability to access monoclonal antibodies for the early treatment of COVID-19.
This program provides treatment for outpatients with COVID-19 who are at high-risk of progression to severe illness. While the first line of defence against COVID-19 is vaccination, this treatment will help to address the growing number of hospitalizations in high-risk individuals.
A monoclonal antibody is a type of protein that attaches to the spike protein of the COVID-19 virus and prevents the virus from entering and infecting healthy cells within the body. This therapy may help reduce the risk of progressing from mild or moderate COVID-19 to severe infection that requires hospitalization for high-risk individuals.
Initial studies show that COVID-19 monoclonal antibody therapy reduces hospitalization by 71% and reduces death by 70% in high-risk COVID-positive patients.
The Monoclonal Antibody Therapy Clinic is located at Sault Area Hospital 750 Great Northern Road.
NOTE: Each referral will be considered based on Provincial medication allocation.
Patients who test positive for COVID-19 and have symptoms lasting seven (7) days or less are eligible if they meet the criteria below.
Unvaccinated individuals – those over the age of 60 OR those under the age of 60 with the following risk factors: Chronic heart disease (excluding hypertension), Chronic Lung disease, Moderate to severe asthma, Obesity, Metabolic disease (including diabetes), Chronic Kidney Disease, Cerebral Palsy, Intellectual Disability, Sickle Cell, Chronic Liver disease, have cancer or other immune suppressing conditions/medications, or are pregnant.
Vaccinated individuals – those over the age of 70, or over 50 and indigenous with single medical condition. Those who are on active chemotherapy due to cancer, bone marrow transplants, solid organ transplants, or are on certain immune suppressing medications.
Patients need to be able to get to Sault Area Hospital while following public health guidelines by driving directly to the hospital and driving directly home.
At this time, the therapy can only be administered at the COVID-19 Clinic – Outpatient Clinic located at Sault Area Hospital.
On the day of your infusion, you’ll meet with your physician and nursing team to answer questions, and you’ll get your vital signs checked. If you agree to the infusion, you’ll have an intravenous placed. You’ll get a 60-minute (minimum) infusion of the medication and be monitored for another 60 minutes afterwards. You can expect to be at SAH for 2.5-3 hours. After this, you’ll go home and continue your isolation as directed by Algoma Public Health. There are no further doses needed.
There are very few side effects described, and many of them are since patients have COVID-19. Patient are monitored for allergic reactions which are rare.
Patients are still considered contagious and must continue to follow all public health guidelines, which include isolation for ten days. They are permitted to leave isolation for medical treatments.
Patients will be referred to the clinic by Algoma Public Health, or their health provider. For more information, contact: 705-759-3691 or email email@example.com.
Patients accessing the Monoclonal Antibody Therapy Clinic will be provided instructions on how to access the clinic directly and are not to present through an entrance – screening station.